EGFR and prostate cancer: Top relevant biological pathways included: ‘PI3K-KAT signalling pathway’, ‘ERBB signalling pathway’, ‘pathways in cancer’, ‘proteoglycans in cancer’, ‘platinum drug resistance’, ‘prostate cancer’, ‘type I diabetes mellitus’, ‘MAPK signalling pathway’ and ‘focal adhesion’.